OCED is managing more than $25 billion in funding from BIL and IRA, funding demonstrations across multiple technologies, including clean hydrogen, carbon management, advanced nuclear reactors, long-duration energy storage, and industrial decarbonization, as well as demonstration projects in rural or remote areas and on current and former mine land.OCED’s mission is to deliver clean energy demonstration projects at scale in partnership with the private sector to accelerate deployment, market adoption, and the equitable transition to a decarbonized energy system.

Wharton Impact Investment Partners (WIIP) is a student-run venture capital training program and impact investment fund at The Wharton School.

I served as a Vice President on SVB’s Enterprise Software Credit Solutions team based in the New York market. I led the underwriting process from initial due diligence to loan documentation and implementation. I also managed a portfolio of early-stage software startups through downside situations and new funding opportunities. I worked directly with, and developed, 12 junior and senior associates across the Northeast (across 6 six-month rotations). I also served as a super user for the rollout of a new bank operating system, and was recognized as within the Top 5 VPs (out of 120+) for outstanding contributions to system and process improvements in its rollout, and dedication in training and support of other credit teams being onboarded.Internal Leadership:-Co-lead, Ecosystem Pod of the DE&I Council for Technology Banking, North America: worked with upper management across business units on creation and implementation of -SVB’s DE&I initiatives that aligned with their internal goals. -Volunteer Underwriter for Payment Protection Plan: processed PPP loans after hours to support non-tech SMB workforces.

I served as a Senior Associate on SVB’s Enterprise Software Credit Solutions team, first in the NorCal market from November 2018, before joining the New York market team in April 2020. I supported the team in underwriting new opportunities and managing the existing portfolio of early- (starting at Seed) to late-stage (public, $1B+ revenues) software clients.

I completed SVB's formal credit training program focused on underwriting and portfolio management, with two rotations on multiple credit teams per rotation. Teams supported: Project Finance, Climate Technology and Sustainability (fka Energy & Resource Innovation), Fintech, Life Sciences, and Enterprise Software.

Renwick is a small consultancy that worked closely with technical founders to commercialize drug candidates discovered in labs, and supports in corporate strategy, capital structuring, business development, product road mapping, and team expansion. While at Renwick, I researched industry regulation and the competitive landscape for multiple biotechnology/ pharmaceutical early-stage startups’ drug candidates, and assisted in financial modeling and budgeting.

While at H.C. Wainwright, I assisted in drafting multiple equity research reports for a range of biotechnology companies, using synthesis of clinical data reports and analysis of drug candidate competitive landscapes. I helped my director assess company’s market opportunity and investment risks through reviewing SEC filings and clinical trial data.

I canvassed homeowners in the greater Albany area about the health and economic risks of high-volume hydraulic fracturing for natural gas extraction, in support of its ban in New York State.